Dr. Bhanuranjan Das
Also known as: Dr. BRD, Dr. Das, Dr. B. Das
Sun Pharma Industries LtD, Bengal College of Pharmaceutical Science and Research, Indian Institute of Technology BHU, National Institute of Pharmaceutical Education and Research
0000-0003-4728-6299
About
Dr. Bhanuranjan Das is a passionate and multidisciplinary researcher with strong expertise in medicinal chemistry and pharmaceutical sciences. He holds a Ph.D. from the Indian Institute of Technology (IIT) BHU, where his research focused on neurodegenerative diseases, particularly the role of protein aggregation in Alzheimer’s disease. His scientific work spans synthetic chemistry, molecular modeling, molecular docking and dynamics simulations, DFT calculations, QSAR modeling, and pharmacophore-based drug design.
He also holds an M.S. (Pharm.) in Medicinal Chemistry from NIPER Kolkata, during which he conducted one year of intensive research at CSIR-IICB (Kolkata), gaining foundational experience in drug discovery and chemical biology.
Dr. Das has over 1.5 years of academic teaching experience as an Assistant Professor at the Bengal College of Pharmaceutical Sciences and Research, where he taught medicinal chemistry and mentored undergraduate and postgraduate students.
Currently, he serves as a Research Manager in Chemical R&D at Sun Pharma Industries Ltd., where he is actively involved in API process development, method design, impurity profiling (including nitrosamines and other Genotoxic impurities), and scaling of laboratory processes to the plant level.
He has published 20+ research articles in reputed international journals such as ACS Chemical Neuroscience, Advanced Synthesis & Catalysis, Bioorganic Chemistry, and ChemistrySelect, among others. His research contributions have added valuable insights to the fields of drug discovery, neuropharmacology, and synthetic methodologies.
As a recognized expert in the field, Dr. Das is also a regular peer reviewer for international journals, including Scientific Reports (Nature Publishing Group), Discover Applied Sciences (Springer Nature), and Brain Research (Elsevier), contributing to the advancement and integrity of scientific publication.
Employment
-
Sun Pharma Industries LtD Research Manager2024 - Present
-
Bengal College of Pharmaceutical Science and Research Assistant Professor2019 - 2020
Education
-
Indian Institute of Technology BHU PhD2021 - 2023
-
National Institute of Pharmaceutical Education and Research MS(Pharm)2017 - 2019
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Discovery and characterization of novel pyridone and furan substituted ligands of choline acetyltransferase Save
- In Silico Identification of Potential Inhibitors for Dengue Virus NS5 Methyltransferase: Molecular Docking, Dynamics, DFT, and ADME Analysis Save
- Discovery and characterization of novel pyridone and furan substituted ligands of choline acetyltransferase Save
- Virtual screening and molecular dynamics investigations using natural compounds against autotaxin for the treatment of chronic pain Save
- Catalyzing a Cure: Discovery and development of LRRK2 inhibitors for the treatment of Parkinson’s disease Save
- Integrated use of ligand and structure-based virtual screening, molecular dynamics, free energy calculation and ADME prediction for the identification of potential PTP1B inhibitors Save
- Unveiling of Indanone‐Benzimidazole Hybrids as Anti‐Alzheimer's Agents: Computational and Experimental Studies Save
- Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer’s disease Save
- Characterization, DFT study and evaluation of antioxidant potentials of mycosporine-like amino acids (MAAs) in the cyanobacterium Anabaenopsis circularis HKAR-22 Save
- Artificial intelligence assisted identification of potential tau aggregation inhibitors: ligand- and structure-based virtual screening, in silico ADME, and molecular dynamics study Save